RSS Newsfeeds

See all RSS Newsfeeds

Jul 31, 2017 9:00 AM ET

Sepsis Diagnostics – Global Market Outlook (2016-2022)

iCrowdNewswire - Jul 31, 2017

The “Sepsis Diagnostics – Global Market Outlook (2016-2022)” report has been added to Research and Markets’ offering.

The Global Sepsis Diagnostics market is expected to reach $659.36 million by 2022 growing at a CAGR of 10.4%.

This life-threatening condition of Sepsis arises when the body’s response to infection injures its own tissues and organs; the rise in number of the situations is demanding more diagnostics.

Rising health concerns such as Cancer, Diabetes, Major Trauma, and Burns etc. are depleting the immune system among all age groups, which has given rise to the demand for the Sepsis diagnostics market.

Moreover, increasing surgical procedures, exponential rise in incidence of hospital-acquired infections and growth in the number of product approvals are supporting the growth of this market. On the other hand, lack of standard protocols and awareness and shortage of skilled staff are the hindering the same.

Methods Covered:

– Automated Diagnostics
– Conventional Diagnostics

Products Covered:

– Assay Kits & Reagents
– Blood Culture Media
– Instruments
– Software

Pathogens Covered:

– Fungal Sepsis
– Bacterial Sepsis

– Gram-Negative Bacterial Sepsis
– Gram-Positive Bacterial Sepsis

– Other Pathogens

Technologies Covered:

– Flow Cytometry
– Immunoassays
– Microbiology
– Molecular Diagnostics

Applications Covered:

– Laboratory Testing
– Point-Of-Care Testing

Key Topics Covered:

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porters Five Force Analysis

5 Global Sepsis Diagnostics market, By Method

6 Global Sepsis Diagnostics market, By Product

7 Global Sepsis Diagnostics market, By Pathogen

8 Global Sepsis Diagnostics market, By Technology

9 Global Sepsis Diagnostics market, By Application

10 Global Sepsis Diagnostics market, By Geography

11 Key Developments

12 Company Profiling

– Abbott Diagnostics
– Beckman Coulter (Danaher)
– Becton, Dickinson & Co. (BD)
– Bio-Rad Laboratories
– bioM?rieux
– Bruker Corporation
– Cepheid
– Chembio Diagnostic Systems
– Nanosphere, Inc.
– Ortho-Clinical Diagnostics
– Roche Diagnostics
– Siemens Healthcare Diagnostics
– T2 Biosystems, Inc.
– Thermo Fisher Scientific
– Trinity Biotech

For more information about this report visit https://www.researchandmarkets.com/research/29wz2s/sepsis

Contact Information:

Research and Markets,
Laura Wood,
Senior Manager.
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
Related Topics: Diagnostics (https://www.researchandmarkets.com/categories.asp?cat_id=59&campaign_id=29wz2s)

Via iCrowdNewswire
View Related News >